Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$335M |
| 2 |
Amazon
AMZN
|
+$287M |
| 3 |
Otis Worldwide
OTIS
|
+$260M |
| 4 |
Alibaba
BABA
|
+$245M |
| 5 |
FlexShares iBoxx 3-Year Target Duration TIPS Index Fund
TDTT
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$720M |
| 2 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$365M |
| 3 |
RTN
Raytheon Company
RTN
|
+$357M |
| 4 |
Schwab US Broad Market ETF
SCHB
|
+$212M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$162M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.87% |
| 2 | Healthcare | 13.57% |
| 3 | Financials | 12.24% |
| 4 | Consumer Discretionary | 10.73% |
| 5 | Communication Services | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
VSE Corp
VSEC
$6.01B
| $3.84M | ﹤0.01% |
122,409
+2,479
| +2% | +$56.5K |
|
|
IVC
2677
DELISTED
Invacare Corporation
IVC
| $3.84M | ﹤0.01% |
603,389
+162,874
| +37% | +$1.09M |
|
|
AKRO
2678
DELISTED
Akero Therapeutics
AKRO
| $3.84M | ﹤0.01% |
154,052
+54,190
| +54% | +$1.24M |
|
2679
Napco Security Technologies
NSSC
$1.44B
| $3.83M | ﹤0.01% |
327,644
-1,858
| -0.6% | -$19.5K |
|
2680
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24B
| $3.83M | ﹤0.01% |
39,972
-3,467
| -8% | -$318K |
|
2681
NWPX Infrastructure Inc
NWPX
$1.22B
| $3.81M | ﹤0.01% |
151,794
-3,703
| -2% | -$88.1K |
|
2682
iShares 7-10 Year Treasury Bond ETF
IEF
$47.3B
| $3.8M | ﹤0.01% |
51,093
+32,694
| +178% | +$3.97M |
|
2683
Texas Pacific Land
TPL
$27.3B
| $3.8M | ﹤0.01% |
57,429
+18,927
| +49% | +$1.16M |
|
2684
Byline Bancorp
BY
$1.81B
| $3.79M | ﹤0.01% |
289,695
+11,712
| +4% | +$134K |
|
|
LGF.B
2685
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $3.79M | ﹤0.01% |
555,236
-43,073
| -7% | -$298K |
|
|
TPCO
2686
DELISTED
Tribune Publishing Company Common Stock
TPCO
| $3.77M | ﹤0.01% |
377,857
+143,813
| +61% | +$1.29M |
|
|
CONN
2687
DELISTED
Conn's Inc.
CONN
| $3.77M | ﹤0.01% |
373,936
-13,320
| -3% | -$88K |
|
2688
Ceco Environmental
CECO
$4.1B
| $3.76M | ﹤0.01% |
570,359
+220,498
| +63% | +$1.2M |
|
2689
Franklin Covey
FC
$244M
| $3.76M | ﹤0.01% |
175,525
+37,680
| +27% | +$764K |
|
2690
Energy Recovery
ERII
$470M
| $3.75M | ﹤0.01% |
493,352
+16,290
| +3% | +$129K |
|
2691
Oric Pharmaceuticals
ORIC
$1.39B
| $3.74M | ﹤0.01% |
+110,852
| New | +$3.54M |
|
2692
Civista Bancshares
CIVB
$605M
| $3.74M | ﹤0.01% |
242,657
+63,658
| +36% | +$926K |
|
2693
Ovid Therapeutics
OVID
$474M
| $3.73M | ﹤0.01% |
505,487
+435,638
| +624% | +$2.04M |
|
2694
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
| $3.72M | ﹤0.01% |
4,561,995
+460,451
| +11% | +$37.1M |
|
|
EIGR
2695
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $3.72M | ﹤0.01% |
12,921
+2,190
| +20% | +$646K |
|
2696
Paysign
PAYS
$519M
| $3.71M | ﹤0.01% |
381,985
+18,547
| +5% | +$137K |
|
2697
Citizens
CIA
$235M
| $3.7M | ﹤0.01% |
617,177
-4,561
| -0.7% | -$26.2K |
|
2698
TherapeuticsMD
TXMD
$23.6M
| $3.69M | ﹤0.01% |
59,097
+5,502
| +10% | +$320K |
|
2699
Allient
ALNT
$1.61B
| $3.69M | ﹤0.01% |
156,804
+18,298
| +13% | +$382K |
|
2700
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.6B
| $3.69M | ﹤0.01% |
6,104,215
+780,721
| +15% | +$45.5M |
|
Similar funds
Northern Trust's Q2 2020 Portfolio in Review
As of Q2 2020, Northern Trust held 4,386 positions worth $422B, up 21% from $348B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Northern Trust's Q2 2020 filing shows 169 new, 2,281 increased, 1,710 reduced and 126 closed positions. Its largest new stake was Otis Worldwide: 5,015,118 shares worth $285M. The largest sale was Allergan plc, an estimated $720M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Northern Trust's largest Q2 2020 buy was Otis Worldwide: 5,015,118 shares worth $285M.
- Northern Trust added most to AbbVie in Q2 2020, an estimated $335M increase.
- Northern Trust's biggest Q2 2020 reduction was FlexShares Global Upstream Natural Resources Index Fund, cutting an estimated $365M.
- Northern Trust fully exited Allergan plc in Q2 2020, selling an estimated $720M.
- Northern Trust's ten largest holdings make up 21% of its $422B portfolio in Q2 2020.
- Northern Trust opened 169 new positions and closed 126 in Q2 2020.
- Northern Trust's portfolio value rose 21% quarter-over-quarter to $422B.
Based on Northern Trust's 13F filing for Q2 2020, filed 14 Aug 2020.